分化型甲状腺癌患者随访中同步18F-2-[18F]FDG PET/MR与PET/CT的比较
本研究对40例已行甲状腺全切除和放射性碘消融的分化型甲状腺癌患者,在单次注射18F-FDG后序贯行PET/MR与PET/CT检查并随访至少6个月。PET/MR阳性11例、PET/CT阳性10例,PET/MR检出33个肿瘤病灶、PET/CT检出30个;结论认为FDG PET研究在血清Tg升高的分化型甲状腺癌患者中诊断准确性高,PET/MR提供与PET/CT相似的信息。
要点
- 40例分化型甲状腺癌患者单次注射18F-FDG后序贯行PET/MR与PET/CT,随访至少6个月。
- PET/MR阳性11例、检出33个病灶;PET/CT阳性10例、检出30个病灶。
- 12例初始PET阴性且血清Tg可测者中仅1例颈部复发,11例经验性高活度131I治疗未发现肿瘤病灶。
核心结论
- 本研究证实FDG PET研究在血清Tg水平升高的分化型甲状腺癌患者中诊断准确性高,并显示PET/MR提供与PET/CT相似的信息。
研究设计与样本
- 单次注射18F-FDG后,对40例既往行甲状腺全切除和放射性碘消融的连续分化型甲状腺癌患者序贯行PET/MR与PET/CT检查。
- 所有患者随后随访至少6个月。
主要发现
- PET/MR阳性11例,PET/CT阳性10例。
- PET/MR检出33个肿瘤病灶,PET/CT检出30个。
- 12例初始PET阴性且血清Tg可测的患者随访中仅1例出现颈部复发,其余11例接受经验性高活度131I治疗未发现肿瘤病灶。
- 17例初始血清Tg水平<2 ng/mL的患者未发生复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: 18F-FDG PET/CT is the most accurate imaging modality in differentiated thyroid cancer (DTC) patients with either an aggressive histology, an absence of radioiodine uptake in neoplastic foci, or in the absence of imaging abnormalities in patients with an elevated serum thyroglobulin (Tg) level that progresses with time. We evaluated the diagnostic performance of FDG PET/MR in comparison with that of PET/CT. METHODS AND RESULTS: Following the injection of a single 18F-FDG activity, PET/MR and PET/CT were sequentially performed in 40 consecutive patients with DTC previously treated with total thyroidectomy and radioiodine ablation. All patients were then followed up for at least 6 months. PET/MR was positive in 11 patients and PET/CT in 10. PET/MR detected 33 tumor foci and PET/CT 30. During the follow-up of the 12 patients with negative initial PET studies and with a detectable serum Tg, only one patient had a neck recurrence and the administration of an empiric high activity of 131I in the other 11 patients did not reveal any tumor focus. In the 17 patients with an initial serum Tg level < 2 ng/mL, no recurrence occurred. CONCLUSION: This study confirms the high diagnostic accuracy of FDG PET studies in DTC patients with elevated serum Tg levels and shows that PET/MR brings similar information as compared to PET/CT imaging.
引用
- Klain M, Nappi C, Nicolai E, et al. Comparison of simultaneous 18F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2020. PMID: 32601803. doi:10.1007/s00259-020-04938-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。